Home    Back

 Drug    DrugBank | All Description Patterns

   e.g. "Sirolimus", "Adalimumab"

A    B    C    D    E    F    G    H     I     J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    other

57 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   Drug (Description in trials)   DrugBank   KEGG DRUG  KEGG GENES
 [Number of genes] 
 KEGG PATHWAY 
 [Number of pathways] 
 Disease ID
 [Number of diseases] 
 1   0 mg prednisone   Prednisone   D00473   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [1]
44 
 2   5 mg prednisone   Prednisone   D00473   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [1]
44 
 3   Abatacept   Abatacept   D03203   [2] CD80, CD86   [12] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis   [24]
11,
13,
19,
41,
44,
46,
49,
50,
51,
53,
55,
60,
65,
84,
93,
96,
97,
107,
164,
222,
271,
284,
285,
300 
 4   Avacopan   Avacopan   D11093   [1] C5AR1   [3] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection   [4]
43,
44,
222,
223 
 5   Azathioprin-ratiopharm® 25 mg filmtabletten   -   -   -   -   [1]
44 
 6   Azathioprine   Azathioprine   D00238, D03033   -   -   [18]
11,
13,
19,
35,
42,
43,
44,
45,
46,
49,
65,
66,
85,
94,
95,
96,
97,
162 
 7   Azathioprine 25 mg   Azathioprine   D00238, D03033   -   -   [1]
44 
 8   Belimumab   Belimumab   D03068   [1] TNFSF13B   [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   [8]
11,
43,
44,
46,
49,
51,
53,
222 
 9   Benralizumab   Benralizumab   D09874   [1] IL5RA   [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer   [2]
44,
45 
 10   Blisibimod   Blisibimod   D10311   -   -   [5]
43,
44,
49,
63,
66 
 11   Ccx168   -   -   -   -   [6]
43,
44,
66,
109,
222,
223 
 12   Chimeric monoclonal antibody, igg4 subtype   -   -   -   -   [2]
43,
44 
 13   Corticosteroid   -   -   -   -   [10]
13,
42,
43,
44,
45,
66,
84,
96,
97,
222 
 14   Corticosteroid and azathioprine   Azathioprine   D00238, D03033   -   -   [4]
42,
43,
44,
45 
 15   Cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   [43]
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331 
 16   Cyclophosphamidum   Cyclophosphamide   D00287, D07760   -   -   [1]
44 
 17   Cyclophosphamidum 500 mg   Cyclophosphamide   D00287, D07760   -   -   [1]
44 
 18   Endoxan® 500 mg   -   -   -   -   [1]
44 
 19   Galen® tablet   -   -   -   -   [2]
43,
44 
 20   Glucocorticoid (gc)   -   -   -   -   [2]
43,
44 
 21   Glucocorticoids   -   -   -   -   [6]
40,
41,
43,
44,
60,
62 
 22   Glucocorticoids (gc)   -   -   -   -   [2]
43,
44 
 23   Glucocorticoids - reduced dose   -   -   -   -   [2]
43,
44 
 24   Glucocorticoids - standard dose   -   -   -   -   [2]
43,
44 
 25   Gusperimus   Gusperimus   D08032   -   -   [1]
44 
 26   Ifx-1   -   -   -   -   [3]
43,
44,
269 
 27   Mabthera®   -   -   -   -   [6]
13,
35,
43,
44,
46,
93 
 28   Mepolizumab   Mepolizumab   D04923   [1] IL5   [13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease (IBD), Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation   [4]
44,
45,
98,
162 
 29   Mesna   Coenzyme m   -   -   -   [9]
13,
44,
45,
49,
51,
60,
65,
96,
164 
 30   Metex 2,5 mg tabletten   -   -   -   -   [1]
44 
 31   Methotrexate   Methotrexate   D00142, D02115   [2] DHFR, DHFR2   [4] Antifolate resistance, Folate biosynthesis, Metabolic pathways, One carbon pool by folate   [33]
11,
13,
19,
34,
35,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
55,
56,
60,
62,
65,
84,
93,
96,
97,
162,
164,
172,
256,
271,
284,
285,
326,
331 
 32   Methotrexate 2.5 mg   Methotrexate   D00142, D02115   [2] DHFR, DHFR2   [4] Antifolate resistance, Folate biosynthesis, Metabolic pathways, One carbon pool by folate   [1]
44 
 33   Methotrexate 25 mg   Methotrexate   D00142, D02115   [2] DHFR, DHFR2   [4] Antifolate resistance, Folate biosynthesis, Metabolic pathways, One carbon pool by folate   [1]
44 
 34   Metoject 10 mg/ml, solution injectable en seringue pré-remplie   Methotrexate   D00142, D02115   [2] DHFR, DHFR2   [4] Antifolate resistance, Folate biosynthesis, Metabolic pathways, One carbon pool by folate   [1]
44 
 35   Naltrexone   Naltrexone   D02095, D05113   [3] OPRD1, OPRK1, OPRM1   [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   [11]
6,
10,
13,
40,
41,
42,
43,
44,
45,
96,
97 
 36   Naltrexone hydrochloride   Naltrexone   D02095, D05113   [3] OPRD1, OPRK1, OPRM1   [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   [7]
10,
40,
41,
42,
43,
44,
45 
 37   Pednisone   -   -   -   -   [2]
43,
44 
 38   Prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [38]
11,
13,
25,
26,
35,
38,
39,
41,
43,
44,
45,
46,
49,
50,
51,
56,
60,
61,
63,
64,
65,
66,
75,
81,
84,
85,
95,
96,
97,
113,
145,
162,
222,
269,
271,
296,
299,
300 
 39   Prednison acis® 20 mg   -   -   -   -   [2]
43,
44 
 40   Prednison acis® 5 mg   -   -   -   -   [2]
43,
44 
 41   Prednisone   Prednisone   D00473   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [43]
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331 
 42   Prednisone tablets, usp   Prednisone   D00473   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [3]
41,
43,
44 
 43   Recombinant humanized monoclonal antibody specific for human il-5   -   -   -   -   [2]
44,
45 
 44   Reslizumab   Reslizumab   D08985   [1] IL5   [13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease (IBD), Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation   [3]
44,
45,
98 
 45   Rituximab   Rituximab   D02994   [1] MS4A1   [1] Hematopoietic cell lineage   [42]
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331 
 46   Rituximab (arm a)   Rituximab   D02994   [1] MS4A1   [1] Hematopoietic cell lineage   [2]
43,
44 
 47   Rituximab (arm b)   Rituximab   D02994   [1] MS4A1   [1] Hematopoietic cell lineage   [2]
43,
44 
 48   Ro0452294/v01   -   -   -   -   [2]
43,
44 
 49   Ro0452294/v02   -   -   -   -   [3]
35,
43,
44 
 50   Same   Ademetionine   D07128   -   -   [15]
6,
14,
22,
43,
44,
46,
47,
49,
50,
60,
84,
93,
96,
97,
172 
 51   Sb-240563   -   -   -   -   [3]
44,
45,
98 
 52   Sb-240563 (mepolizumab)   Mepolizumab   D04923   [1] IL5   [13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease (IBD), Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation   [2]
44,
45 
 53   Sulfamethoxazole   Sulfamethoxazole   D00447   -   -   [4]
44,
49,
85,
299 
 54   Trimethoprim   Trimethoprim   D00145, D06236   -   -   [6]
36,
44,
49,
60,
85,
299 
 55   Trimethoprim sulfamethoxazole   Sulfamethoxazole   D00447   -   -   [1]
44 
 56   Yellow fever vaccine   Yellow fever vaccine   D06347   -   -   [7]
40,
44,
46,
50,
51,
52,
53 
 57   Yellow fever vaccine (17d)   Yellow fever vaccine   D06347   -   -   [7]
40,
44,
46,
50,
51,
52,
53 

Back to top